Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
6,070.00
+50.00 (0.83%)
Last updated: Aug 12, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Food | 628.43B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Food Growth | 10.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MRO | 610.30B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
MRO Growth | 0.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical | 411.91B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Growth | 17.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -27.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 8.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 17.72B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 1.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -27.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 8.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Consolidated Adjustment | -27.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 8.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 1,641.16B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 8.73% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 19.61B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | -32.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 7.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 522.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -27.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 8.49% |
Log In |
Log In |
Log In |
Log In | Upgrade
|